Silmäasema Oyj: 10 largest shareholders after the end of the Initial Public Offering
Stock Exchange Release 14 June 2017, at 4.30 p.m.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
The ten largest registered shareholders of Silmäasema Oyj (the "Company") and their shares of ownership before the Initial Public Offering are shown in the table below.
| Shareholder | The number of shares | % |
|
6,221,440 | 68.0 |
|
384,000 | 4.2 |
|
320,000 | 3.5 |
|
320,000 | 3.5 |
|
320,000 | 3.5 |
|
320,000 | 3.5 |
|
160,000 | 1.7 |
|
64,000 | 0.7 |
|
64,000 | 0.7 |
|
48,064 | 0.5 |
| Ten largest, in total | 8,221,504 | 89.9 |
| Other shareholders | 928.280 | 10.1 |
| In total | 9,149,784 | 100.0 |
|
1 Torsti Sihvola's holdings notified in the Company's Offering Circular dated 26 May 2017 include also the Company's shares owned through ETS-Holding Oy which is entirely owned by Torsti Sihvola, and the holdings of his related parties. However, this release only announces the direct shareholding of Torsti Sihvola. |
||
The ten largest registered shareholders of the Company's and their shares of ownership after the Initial Public Offering are shown in the table below (13 June 2017 Euroclear Finland Ltd).
| Shareholder | The number of shares | % |
|
3,605,808 | 25.3 |
|
850,000 | 6.0 |
|
590,000 | 4.1 |
|
570,000 | 4.0 |
|
500,000 | 3.5 |
|
384,000 | 2.7 |
|
365,000 | 2.6 |
|
327,000 | 2.3 |
|
320,000 | 2.2 |
|
285,000 | 2.0 |
| Ten largest, in total | 7,796,808 | 54.7 |
|
Other shareholders 3 |
6,451,997 | 45.3 |
| In total | 14,248,805 | 100.0 |
|
1 The Company has received a notification from Intera Fund II Ky ("Intera") on 12 June 2017 of a change in shareholding according to Chapter 9, section 10 of the Finnish Securities Market Act, according to which Intera's holding of the shares and votes of the Company decreased to 35.03 percent (a total of 4,991,582 shares and votes) and Intera's holding through financial instruments increased above the threshold of 5 percent on 9 June 2017 (a total of 1,229,858 shares and votes, which equals to 8.63 percent of all the shares and votes in the Company). The change was due to a share lending agreement signed by Intera and Nordea Bank AB (publ), Finnish Branch ("Nordea") in connection with the Initial Public Offering of the Company on 9 June 2017, according to which Intera committed to lend 1,229,858 existing shares in the Company to Nordea. The share lending did not affect the aggregate total holdings of Intera, which amounted to 6,221,440 shares before the aforementioned share lending agreement. As a part of the Initial Public Offering, Intera resold a total of 2,615,632 shares of the Company, on account of which Intera currently holding in the Company totals 3,605,808 shares, of which Intera's direct holding totals 2,375,950 shares and votes and holding through financial instruments (the share lending agreement) totals 1,229,858 shares and votes. 2 Should Nordea use the whole amount lent by Intera (1,229,858 shares) to cover over-allotments, Intera's holding in the Company would total 2,375,950 shares and votes, which equals to 16.7 percent of all the shares and votes in the Company. 3 Out of other shareholders, 2,513,046 shares and 17.6 percent of shares and votes are nominee registered. |
||
Additional information
Pasi Kohmo, CEO, Silmäasema, +358 50 331 7015, pasi.kohmo@silmaasema.fi
Kati Räihä, Director, Marketing and Communications, Silmäasema, +358 50 416 6764, kati.raiha@silmaasema.fi
Silmäasema in brief
Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain with 25.3 per cent market share. The Silmäasema chain has 148 stores and 13 eye clinics as well as eight stores in Estonia. The Silmäasema chain employs close to 1,000 eye healthcare professionals. In 2016, the Silmäasema chain conducted around 210,000 optician's eye examinations, 190,000 ophthalmologist's appointments and over 15,000 cataract and refractive surgeries. Silmäasema's Group net sales were 101.3 million euros in 2016 and adjusted EBITDA was 12.0 million euros.
DISCLAIMER
The information contained herein is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, Hong Kong, South Africa, Singapore or Japan.
These written materials do not constitute an offer of securities for sale in the United States, nor may the securities be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended, and the rules and regulations thereunder. Silmäasema Oyj (the "Company") does not intend to register any portion of the offering in the United States or to conduct a public offering of securities in the United States.
The issue, exercise and/or sale of securities in the initial public offering are subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company, Nordea Bank AB (publ), Finnish Branch ("Nordea") nor OP Corporate Bank plc ("OP") assume any responsibility in the event there is a violation by any person of such restrictions.
Nordea and OP are acting exclusively for the Company and for no-one else in connection with any transaction mentioned in this announcement and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to any such transaction and will not be responsible to any other person for providing the protections afforded to its clients, or for advising any such person on the contents of this announcement or in connection with any transaction referred to in this announcement. The contents of this announcement have not been verified by Nordea or OP and neither Nordea nor OP accept liability for this information included in this announcement.
The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Investors must neither accept any offer for, nor acquire, any securities to which this document refers, unless they do so on the basis of the information contained in the applicable prospectus published or offering circular distributed by the Company.
The Company has not authorized any offer to the public of securities in any Member State of the European Economic Area other than Finland. With respect to each Member State of the European Economic Area other than Finland and which has implemented the Prospectus Directive (each, a "Relevant Member State"), no action has been undertaken or will be undertaken to make an offer to the public of securities requiring publication of a prospectus in any Relevant Member State. As a result, the securities may only be offered in Relevant Member States (a) to any legal entity which is a qualified investor as defined in the Prospectus Directive; or (b) in any other circumstances falling within Article 3(2) of the Prospectus Directive. For the purposes of this paragraph, the expression an "offer of securities to the public" means the communication in any form and by any means of sufficient information on the terms of the offer and the securities to be offered so as to enable an investor to decide to exercise, purchase or subscribe the securities, as the same may be varied by any measure implementing the Prospectus Directive in that Relevant Member State and the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU.
These written materials do not constitute an offer of the securities referred to herein to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the securities referred to herein. This communication is directed only at (i) persons who are outside the United Kingdom or (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2) of the Order (all such persons together being referred to as "relevant persons"). Any investment activity to which this communication relates will only be available to and will only be engaged with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Silmäasema Oyj via GlobeNewswire